A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...
An Australian startup has unveiled the world’s first commercial biologic. Melbourne-based Cortical Labs launched the CL1 at ...
An investigational induced pluripotent stem cell-derived CAR natural ... among patients with B-cell lymphomas, according to results from a phase I first-in-human trial. For the 86 patients ...
Being fruitful, they multiply into a ball of many cells, a shimmering sphere of human potential. Scientists have long dreamed of plucking those naive cells from a young human embryo and coaxing ...
has been granted a non-exclusive license to use Nona's H2L2 Harbour Mice ® platform to develop fully human antibodies. This will enable UAB researchers to pursue breakthroughs in B cell ...
SEATTLE, March 17, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today reported financial results ...